MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakagawa, Y.
Right arrow Articles by Moldeus, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakagawa, Y.
Right arrow Articles by Moldeus, P.

Metabolism and cytotoxicity of propyl gallate in isolated rat hepatocytes: effects of a thiol reductant and an esterase inhibitor

Y Nakagawa, K Nakajima, S Tayama and P Moldeus

Department of Toxicology, Tokyo Metropolitan Research Laboratory of Public Health, Japan.

The relationship between the metabolism and the cytotoxic effects of propyl gallate (PG) has been studied in freshly isolated rat hepatocytes. Addition of PG (0.5-2.0 mM) to the hepatocytes elicited concentration-dependent cell death, accompanied by decreases in intracellular ATP, adenine nucleotide pools, glutathione, and protein thiols. The rapid loss of ATP preceded the onset of cell death. PG in the hepatocyte suspensions was converted to gallic acid, 4-O-methyl- gallic acid, and other minor products over time. In addition, PG was converted to a dimer [dipropyl-4,4',5,5',6,6'-hexahydroxydiphenate (PG- dimer)] and ellagic acid via autooxidation. In comparisons of the toxic effects of PG and its metabolites at concentrations of 2 mM, the parent compound PG was the most toxic. Pretreatment of hepatocytes with diazinon (100 microM), an esterase inhibitor, enhanced PG-induced cytotoxicity. This was accompanied by delay of PG loss and inhibition of gallic acid formation. The cytotoxicity of PG was also enhanced by addition of the thiol reductant dithiothreitol (4 mM), although intracellular levels of glutathione and protein thiols were maintained during the incubation period. Dithiothreitol did not affect the hydrolysis of PG to gallic acid by esterases but did delay the conversion of PG and prevented the formation of PG-dimer. In isolated hepatic mitochondria, PG elicited a concentration-dependent increase in the rate of state 4 oxygen consumption, indicating an uncoupling effect. In contrast, PG-dimer inhibited the rate of state 3 oxygen consumption. Based on the respiratory control index, the order of potency for impairment of mitochondria was PG > PG-dimer > gallic acid = 4-O-methyl-gallic acid = ellagic acid - propyl alcohol. These results indicate (a) that PG-induced hepatotoxicity is mediated by the parent compound and not its metabolites, (b) that toxicity is associated with ATP depletion apparently independently of cellular thiol depletion, and (c) that mitochondria may represent critical targets of PG-induced cytotoxicity.

Volume 47, Issue 5, pp. 1021-1027, 05/01/1995
Copyright © 1995 by American Society for Pharmacology and Experimental Therapeutics







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1995 by the American Society for Pharmacology and Experimental Therapeutics